RecruitingNCT06377527
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
Sponsor
M.D. Anderson Cancer Center
Enrollment
2,000 participants
Start Date
Jul 10, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with mesonephric-like adenocarcinoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06377527